Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has updated its date references, adding new dates in March 2025 while removing older dates from late February 2025.SummaryDifference0.5%
- Check14 days agoChange DetectedThe page has been updated to reflect changes in eligibility criteria for participants, specifically regarding birth control practices and pregnancy testing requirements. Additionally, there are modifications to the treatment protocols involving Pembrolizumab and other drugs.SummaryDifference30%
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with updated dates for upcoming events or deadlines.SummaryDifference1%
- Check42 days agoChange DetectedThe website has been updated to version v2.14.2, with new additions on January 24 and 27, while the previous version v2.14.1 has been removed.SummaryDifference0.3%
- Check49 days agoChange DetectedDifference0.1%
Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.